Stryker: Canaccord Genuity cuts rating to hold from buy, target to $300 from $385
SYK•Canaccord Genuity cut its rating on Stryker to hold from buy and lowered its target price to $300 from $385.
Related News
Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
QQQ•
Willdan completes $285 million acquisition of Mantis Innovation
WLDN•
AbbVie gains after lifting FY profit forecast
ABBV•
Nasdaq trade halt: volatility trading pause at 10:01 am
CHWM•
American Express partners with Home Bargains for in-store, online payments
AXP•